LAS VEGAS, NEVADA — (MARKET WIRE) — China Health Management Corp. (Nevada Company) (Other OTC:CNHC.PK – News) is pleased to announce that its Richland International Hospital has signed a $1.15USD million contract with OLYMPUS for Minimally Invasive Endoscopes.
After several meetings with the Deputy Regional Director, Deputy Division Manager and Technical Managers from OLYMPUS of China in November and December, Richland International Hospital has signed a $1.15USD million contract with OLYMPUS on January 10, 2008 to set up the first Minimally Invasive Operating Theatre in China.
The project will begin before the Chinese New Year and OLYMPUS will be responsible for all technical planning, support and maintenance service. OLYPUS will continue to contribute to the realization of better healthcare by pursuing the themes of patient friendly medical care that supports early detection and treatment of diseases, high reliability through products of outstanding quality and performance, and excellent efficiency through products and services that enhance the effectiveness of medical services to improve quality of life for patients.
Minimal invasive surgery has come into wide use during surgical procedures in a variety of clinical disciplines, including general surgery, ear, nose and throat surgery, gynecological, urology, neuro, pediatric and thoracic surgery. We believe that greater use of endoscopes in surgical procedures will not only help to shorten hospital stays and alleviate burden on patients, but will also contribute to greater efficiency in healthcare.
OLYMPUS’ minimally invasive diagnosis and treatment products for endoscopic surgery enables effective medical procedures and treatments without open abdominal surgery. These factors include improved image quality through the advent of high-resolution imaging, as well as OLYMPUS’ development of a broad lineup of endotherapy products, treatment equipment and endoscopic surgery apparatus.
China Health Management Corp. is a healthcare management company focused on Operations and Management of hospitals in China. The company’s first target is to become the leader in the high-end healthcare and medical services industry in Kunming city, Yunnan Province, China.